Source: Molecular and Cellular Biochemistry. Unidade: FMRP
Subjects: POLIMORFISMO, RISCO, LEUCEMIA, INFÂNCIA
ABNT
SILVEIRA, Vanessa S. et al. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome. Molecular and Cellular Biochemistry, 2012Tradução . . Disponível em: https://doi.org/10.1007/s11010-011-1220-8. Acesso em: 07 out. 2024.APA
Silveira, V. S., Canalle, R., Scrideli, C. A., Queiroz, R. G. de P., Lopes, L. F., & Tone, L. G. (2012). CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome. Molecular and Cellular Biochemistry. doi:10.1007/s11010-011-1220-8NLM
Silveira VS, Canalle R, Scrideli CA, Queiroz RG de P, Lopes LF, Tone LG. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome [Internet]. Molecular and Cellular Biochemistry. 2012 ;[citado 2024 out. 07 ] Available from: https://doi.org/10.1007/s11010-011-1220-8Vancouver
Silveira VS, Canalle R, Scrideli CA, Queiroz RG de P, Lopes LF, Tone LG. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome [Internet]. Molecular and Cellular Biochemistry. 2012 ;[citado 2024 out. 07 ] Available from: https://doi.org/10.1007/s11010-011-1220-8